New restrictions on use of high-dose simvastatin

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1356卷 / 1期
关键词：
Simvastatin; Homocysteine; Atorvastatin; Myopathy; Diltiazem;
D O I：
10.2165/00128415-201113560-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [21] USE AND SAFETY OF HIGH-DOSE IFOSFAMIDE
    HOLOYE, PY
    ANDERSON, T
    DUELGE, J
    HANSEN, RM
    RITCH, PS
    SEMINARS IN ONCOLOGY, 1982, 9 (04) : 78 - 86
  • [22] High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease
    Stoekenbroek, Robert M.
    Boekholdt, S. Matthijs
    Fayyad, Rana
    Laskey, Rachel
    Tikkanen, Matti J.
    Pedersen, Terje R.
    Hovingh, G. Kees
    HEART, 2015, 101 (05) : 356 - 362
  • [23] The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin on postprandial lipids and endothelial function in patients with the metabolic syndrome
    Olijhoek, Jobien K.
    Hajer, Gideon R.
    Van der Graat, Yolanda
    Dallinga-Thie, Geesje M.
    Visseren, Frank L.
    CIRCULATION, 2006, 114 (18) : 880 - 880
  • [24] High-dose simvastatin falls to achieve primary end point in trial of ACS
    不详
    FORMULARY, 2004, 39 (10) : 480 - 480
  • [25] Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin
    Schick, B. A.
    Laaksonen, R.
    Frohlich, J. J.
    Paiva, H.
    Lehtimaki, T.
    Humphries, K. H.
    Cote, H. C. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 650 - 653
  • [26] Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin
    Schick, B. A.
    Laaksonen, R.
    Frohlich, J. J.
    Paiva, H.
    Lehtimaki, T.
    Humphries, K. H.
    Cote, H. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 199 - 200
  • [27] Effect of high-dose simvastatin on plasma concentration of asymmetric dimethylarginine in hypercholesterolemic subjects
    Vladimirova-Kitova, L. G.
    Terzieva, D. D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 201 - 201
  • [28] Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients
    Ahmed, Tamer A.
    Hayslip, John
    Leggas, Markos
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (06) : 1369 - 1374
  • [29] Researchers Worry About Myopathy Risk for Patients Taking High-Dose Simvastatin
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (03): : 261 - 262
  • [30] Decreased skeletal muscle mitochondrial DNA in patients on high-dose simvastatin therapy
    Schick, Brian
    Côté, Hélène C.
    Laaksonen, Reijo
    Päivä, Hannu
    Lehtimäki, Terho
    Frohlich, Jiri
    CIRCULATION, 2006, 114 (18) : 899 - 899
12345